Modulators of brca1 activity
CA 2259959 A1 · Owner: Ligenfelter, Carol · Inventors: Rubinfeld, Bonnee; Polakis, Paul; Ligenfelter, Carol
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions of matter consisting of a family of related nucleotide sequences that encode proteins, termed BRCA1 Modulator Proteins that bind to the tumor , suppressor gene product BRCA1 and methods of using the nucleotide sequences and the proteins encoded thereby, to diagnose and/or treat disease where the BRCA1 Modulator Proteins have an apparent molecular weight of 45-97 kdaltons and are characterized by having at least one leucine zipper domain and , optionally a zinc finger domain.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 6, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 6, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 6, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.